Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly reply

被引：0
|
作者：
Gomez-Huelgas, Ricardo [1 ,2 ]
Perez-Belmonte, Luis M. [1 ,3 ]
Lopez-Sampalo, Almudena [1 ]
Morilla--Herrera, Juan C.
Bellosta-Ymbert, Jose M. [4 ]
Bernal-Lopez, M. Rosa [1 ,2 ]
机构：
[1] Univ Malaga, Reg Univ Hosp Malaga, BioMed Res Inst Malaga, Dept Internal Med, Malaga, Spain
[2] Inst Hlth Carlos III, Ctr Network Biomed Res Physiopathol Obes & Nutr C, Madrid, Spain
[3] Inst Hlth Carlos III, Ctr Network Biomed Res Cardiovasc Dis CIBERcv, Madrid, Spain
[4] Andalusian Hlth Serv, Malaga Guadalhorce Dist, Long Term Care & Skilled Nursing Unit, Malaga, Spain
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2019年 / 129卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：940 / 940
页数：1
相关论文
共 50 条
  • [41] The role of sodium-glucose co-transporter (SGLT)-2 inhibitors in heart failure management and implications for the kidneys
    Lioudaki, Eirini
    Joslin, Jennifer Ruth
    Trachanatzi, Eirini
    Androulakis, Emmanuel
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (03)
  • [42] The role of sodium-glucose co-transporter 2 inhibitors in myocardial infarction: available evidence and future perspectives
    Tavecchia, Giovanni Amedeo
    Gualini, Elena
    Sacco, Alice
    Oliva, Fabrizio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : i84 - i87
  • [43] The mechanism of action of sodium-glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors
    Leon Jimenez, David
    Gomez Huelgas, Ricardo
    Miramontes Gonzalez, Jose Pablo
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (02) : 409 - 409
  • [44] Sodium-glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome
    Cice, Gennaro
    Calo, Leonardo
    Monzo, Luca
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : I68 - I71
  • [45] Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure
    Takenaka, Tsuneo
    Ohno, Yoichi
    Suzuki, Hiromichi
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (02): : 154 - 157
  • [46] Anti-inflammatory effects of sodium-glucose co-transporter 2 inhibitors on atherosclerosis
    Kang, Yingxiu
    Zhan, Fenfen
    He, Minzhi
    Liu, Zhenjie
    Song, Xiaoxiao
    VASCULAR PHARMACOLOGY, 2020, 133
  • [47] Sodium-glucose co-transporter 2 inhibitors Think twice about diabetic ketoacidosis
    Markey, Annabel G.
    Scott, Taylor A.
    Killen, Judith C.
    Venter, Jan A.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2018, 47 (04) : 223 - 225
  • [48] Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors
    Isaacs, Michelle
    Tonks, Katherine T.
    Greenfield, Jerry R.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (06) : 701 - 704
  • [49] Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors
    Lahnwong, Sarayut
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [50] Sodium-glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome
    Cice, Gennaro
    Calo', Leonardo
    Monzo, Luca
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : I68 - I71
12345